Differential expression of TRAIL and TRAIL receptors in allergic asthmatics following segmental antigen challenge: Evidence for a role of TRAIL in eosinophil survival

Journal of Immunology

Volumn 169, Issue 10, 2002, Pages 5986-5996

  Robertson, Noreen M ^a   Zangrilli, James G ^a   Steplewski, Andrzej ^a   Hastie, Annette ^a   Lindemeyer, Rochelle G ^a   Planeta, Maria A ^a   Smith, Mary K ^a   Innocent, Nathalie ^a   Musani, Ali ^a   Pascual, Rodolfo ^a   Peters, Stephen ^a   Litwack, Gerald ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; APOPTOSIS; ARTICLE; BREATHING MUSCLE; BRONCHUS BIOPSY; BRONCHUS HYPERREACTIVITY; CELL ACTIVITY; CELL COUNT; CELL INFILTRATION; CELL SURVIVAL; CELL TRANSFORMATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EOSINOPHIL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; SMOOTH MUSCLE; STAINING; VASCULAR SMOOTH MUSCLE;

EID: 0037111525     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.10.5986     Document Type: Article

References (42)

1. Poston, R. N., P. Chanez, J. Y. Lacoste, T. Litchfield, T. H. Lee, and J. Bousquet. 1995. Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. Am. Rev. Respir. Dis. 145:918.
2. Bousquet, J., P. Chanez, J. Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, S. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, and F.-B. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033.
3. Bousquet, J., P. Chanez, A. M. Vignola, J. Y. Lacoste, and F. B. Michel. 1994. Eosinophil inflammation in asthma. Am. J. Respir. Crit. Care Med. 150:S33.
4. Ohashi, Y., S. Motojima, T. Fukuda, and S. Makino. 1992. Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am. Rev. Respir. Dis. 145:1469.
5. Ohnishi, T., H. Kita, D. Weiler, S. Sur, J. B. Sedgwick, W. J. Calhoun, W. W. Busse, J. S. Abrams, and G. J. Glesich. 1993. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am. Rev. Respir. Dis. 147:901.
6. De Monchy, J. G., H. F. Kauffman, P. Venge, G. H. Koeter, H. M. Jansen, H. J. Sluiter, and K. De Vries. 1985. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am. Rev. Respir. Dis. 131:373.
7. Dunill, M. S. 1960. The pathology of asthma, with special reference to changes in the bronchial mucosa. J. Clin. Pathol. 13:27.
8. Motojima, S., T. Adachi, K. Manaka, M. Arima, T. Fukuda, and S. Makino. 1996. Eosinophil peroxidase stimulates the release of granulocyte-macrophage colonystimulating factor from bronchial epithelial cells. J. Allergy Clin. Immunol. 98: S216.
9. Rothenberg, M. E., J. Peterson, R. L. Stevens, D. S. Silberstein, D. T. McKenzie, K. F. Austen, and W. F. Owen. 1989. IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodense and sustained antibody-dependent cytotoxicity. J. Immunol. 143:2311.
10. Rothenberg, M. E., W. F. Owen. Jr., D. S. Silberstein, J. Woods, R. J. Soberman, K. F. Austen, and R. L. Stevens. 1988. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J. Clin. Invest. 81:1986.
11. Lopez, A. F., D. J. Williamson, J. R. Gamble, C. J. Begley, J. M. Harlan, S. J. Klebanoff, A. Waltersdorf, S. Wong, S. C. Clark, and M. A. Vadas. 1986. Recombinant granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J. Clin. Invest. 78:1220.
12. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76:959.
13. Bodmer, J. L., K. Burns, P. Schneider, K. Hofmann, V. Steiner, M. Thome, T. Bomand, M. Hahne, M. Schroter, K. Becker, et al. 1997. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6:79.
14. Brojatsch, J., J. Naughton, M. M. Rolls, K. Zingler, and J. A. T. Young. 1996. CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis. Cell 87:845.
15. Pan, G., K. O' Rourke, A. M. Chinnaiyan, R. Gentz, R. Ebner, J. Ni, and V. M. Dixit. 1997. The receptor for the cytotoxic ligand TRAIL. Science 276: 111.
16. Pan. G., J. Ni, Y. F. Wei, G. Yu, R. Gentz, and V. M. Dixit. 1997. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277: 815.
17. Sheridan, J. P., S. A. Marsters, R. M. Pitti, A. Gurney, M. Skubatch, D. Baldwin, L. Ramakrishnan, C. L. Gray, K. Baker, W. I. Wood, et al. 1997. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277:818.
18. Nocentini, G., L. Giunchi, S. Ronchetti, L. T. Krausz, A. Bartoli, R. Moraca, G. Migliorati, and C. Riccardi. 1997. A new member of the tumor necrosis factor/ nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc. Natl. Acad. Sci. USA 94:6216.
19. Goillot, E., J. Raingeaud, A. Ranger, R. I. Tepper, R. J. Davis, E. Harlow, and I. Sanchez. 1997. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc. Natl. Acad. Sci. USA 94:3302.
20. Baichwal, V. R., and P. A. Baeuerle. 1997. Activate NF-κB or die? Curr. Biol. 7:R94.
21. Hsu, H., J. Xiong, and D. V. Goeddel. 1995. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81:495.
22. Jeremias, I., and K. M. Debatin. 1998. TRAIL induces apoptosis and activation of NF-κB. Eur. Cytokine Network 9:687.
23. Schneider, P., M. Thome, K. Burns, J. L. Bodmer, K. Hofmann, T. Kataoka, N. Holler, and J. Tschopp. 1997. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB. Immunity 7:831.
24. Juo, P., C. J. Kuo, S. E. Reynolds, R. F. Konz, J. Raingeaud, R. J. Davis, H. P. Biemann, and J. Blenis. 1997. Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases. Mol. Cell. Biol. 17:24.
25. Wiley, S. R., K. Schooley, P. J. Smolak, W. S. Din, C. P. Huang, J. K. Nicholl, G. R. Sutherland, T. D. Smith, C. Rauch, C. A. Smith, et al. 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673.
26. Smyth, M. J., E. Cretney, K. Takeda, R. H. Wiltrout, L. M. Sedger, N. Kayagaki, H. Yagita, and K. Okumura. 2001. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon-γ-dependent natural killer cell protection from tumor metastasis. J. Exp. Med. 193:661.
27. Griffith, T. S., S. R. Wiley, M. Z. Kubin, L. M. Sedger, C. R. Maliszewski, and N. A. Fanger. 1999. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J. Exp. Med. 189:1343.
28. Liu, S., Y. Yu, M. Zhang, W. Wang, and X. Cao. 2001. The involvement of TNF-α-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-β-stimulated human dendritic cells to tumor cells. J. Immunol. 166:5407.
29. Santini, S. M., C. Lapenta, M. Logozzi, S. Parlato, M. Spada, T. Di Pucchio, and F. Belardelli. 2000. Type-I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 191:1777.
30. Pitti, R. M., S. A. Marsters, S. Ruppert, C. J. Donahue, A. Moore, and A. Ashkenazi. 1996. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271:12687.
31. Walczak, H., M. A. Degli-Esposti, R. S. Johnson, P. J. Smolak, J. Y. Waugh, N. Boiani, M. S. Timour, M. J. Gerhart, K. A. Schooley, C. A. Smith, et al. 1997. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL. EMBO J. 16:5386.
32. Marsters, S. A., J. P. Sheridan, C. J. Donahue, R. M. Pitti, C. L. Gray, A. D. Goddard, K. D. Bauer, and A. Ashkenazi. 1996. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB. Curr. Biol. 6:1669.
33. MacFarlane, M., M. Ahmad, S. M. Srinivasula, T. Fernandes-Alnemri, G. M. Cohen, and E. S. Alnemri. 1997. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. Biol. Chem. 272:25417.
34. Degli-Esposito, M. A., W. C. Dougall, P. J. Smolak, J. Y. Waugh, C. A. Smith, and R. G. Goodwin. 1997. The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet remains an incomplete death domain. Immunity 7:813.
35. Degli-Esposito, M. A., P. J. Smolak, H. Walczak, J. Y. Waugh, C. P. Huang, R. F. DuBose, R. G. Goodwin, and C. A. Smith. 1997. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J. Exp. Med. 186:1165.
36. Emery, J. G., P. McDonnell, M. B. Burke, K. C. Deen, S. Lyn, C. Silverman, E. Dul, E. R. Appelbaum, C. Eichman, R. DiPrinzio, et al. 1998. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J. Biol. Chem. 273:14363.
37. Shaver, J. R., J. G. Zangrilli, S. K. Cho, R. A. Cirelli, M. Pollice, A. T. Hastie, J. E. Fish, and S. P. Peters. 1997. Kinetics of the development and recovery of the lung from IgE-mediated inflammation: Dissociation of pulmonary eosinophilia, lung injury, and eosinophil-active cytokines. Am. J. Respir. Crit. Care Med. 155: 442.
38. Colavita, A. M., A. T. Hastie, A. I. Musani, R. M. Pascual, A. J. Reinach, H. T. Lustine, S. A. Galati, J. G. Zangrilli, J. E. Fish, and S. P. Peters. 2000. Kinetics of IL-10 production after segmental antigen challenge of atopic asthmatic subjects. J. Allergy Clin. Immunol. 106:880.
39. Louahed, J., Y. Zhou, L. Maloy, P. U. Rani, C. Weiss, Y. Tomer, A. Vink, J.-C. Renauld, J. V. Snick, N. C. Nicolaides, et al. 2001. Interleukin 9 promotes influx and local maturation of eosinophils. Blood 97:1035.
40. Hoontrakoon, R., H. Chu, S. J. Gardai, S. E. Wenzel, P. McDonald, V. Fadok, P. M. Henson, and D. Bratton. 2002. Interleukin-15 inhibits spontaneous apoptosis in human eosinophils via autocrine production of granulocyte macrophagecolony stimulating factor and nuclear factor-κB activation. Am. J. Respir. Cell Mol. Biol. 26:404.
41. Temple, R., E. Allen, J. Fordham, S. Phipps, H. Schneider, K. Lindauer, I. Hayes, J. Lockey, K. Pollock, and R. Jupp. 2001. Microarray analysis of eosinophils reveals a number of candidate survival and apoptosis genes. Am. J. Respir. Cell Mol. Biol. 25:425.
42. Lee, J. H., N. Kaminski, G. Dolganov, G. Grunig, L. Koth, C. Solomon, D. J. Erie, and D. Sheppard. 2001. Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types. Am. J. Respir. Crit. Care Med. 25:474.